$144.84
-0.81-0.56%
Last update: Sep 10, 3:37 PM
Gilead Sciences Inc
GILDNASDAQ
Dividend: The dividend Ex-Date is in 5 days
Gilead Sciences Earnings & Forecasts
Gilead Sciences (GILD) earnings history, EPS estimates, revenue forecasts and company guidance.
Earnings Per Share (Non-GAAP)
Quarterly Revenue (Billions)
Gilead Sciences Guidance
Gilead Sciences (GILD) last issued guidance on August 4, 2026 for fiscal year 2026. The company guided earnings per share in the range of $-0.65 - $-0.3, compared to a consensus EPS estimate of $-0.79. Gilead Sciences also guided revenue in the range of $30.1B - $30.4B for the period.
Compared to prior guidance, Gilead Sciences raised its EPS outlook from a previous range of $-1.05 - $-0.65. On the revenue side, the company maintained its revenue forecast from a prior range of $30B - $30.4B.
Gilead Sciences has issued 16 guidance updates between October 27, 2022 and August 4, 2026. During this period, the company raised its outlook 8 times and lowered it 3 times, providing investors with insight into management's evolving expectations.
Recent Earnings Results
| Metric | Q2 '26 | Q1 '26 | Q4 '25 | Q3 '25 |
|---|---|---|---|---|
| Earnings Per Share (Non-GAAP) | ||||
| Estimate | $-7.14 | $1.91 | $1.83 | $2.14 |
| Actual | $-6.75 | $2.03 | $1.86 | $2.47 |
| Surprise | +5.46% | +6.28% | +1.64% | +15.4% |
| Revenue | ||||
| Estimate | $7.40B | $6.92B | $7.64B | $7.46B |
| Actual | $7.80B | $6.96B | $7.92B | $7.77B |
| Surprise | +5.42% | +0.61% | +3.80% | +4.15% |
Analyst Estimates — Forward PeriodsSource: Wall Street consensus
| Metric | Q3 '26E | Q4 '26E | Q1 '27E | Q2 '27E |
|---|---|---|---|---|
| Earnings Per Share (Non-GAAP) | ||||
| Consensus | $2.15 | $2.17 | $2.17 | $2.30 |
| Revenue | ||||
| Consensus | $7.77B | $8.15B | — | — |
